X-48911594-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005660.3(SLC35A2):c.43C>A(p.Pro15Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0223 in 1,163,770 control chromosomes in the GnomAD database, including 226 homozygotes. There are 8,200 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005660.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC35A2 | NM_005660.3 | c.43C>A | p.Pro15Thr | missense_variant | 1/5 | ENST00000247138.11 | NP_005651.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC35A2 | ENST00000247138.11 | c.43C>A | p.Pro15Thr | missense_variant | 1/5 | 1 | NM_005660.3 | ENSP00000247138 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0154 AC: 1740AN: 113199Hom.: 16 Cov.: 25 AF XY: 0.0150 AC XY: 530AN XY: 35347
GnomAD3 exomes AF: 0.0161 AC: 1732AN: 107447Hom.: 7 AF XY: 0.0153 AC XY: 567AN XY: 36957
GnomAD4 exome AF: 0.0231 AC: 24234AN: 1050519Hom.: 210 Cov.: 31 AF XY: 0.0224 AC XY: 7668AN XY: 342897
GnomAD4 genome AF: 0.0154 AC: 1741AN: 113251Hom.: 16 Cov.: 25 AF XY: 0.0150 AC XY: 532AN XY: 35409
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 30, 2017 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 26, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2016 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
SLC35A2-congenital disorder of glycosylation Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at